𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Epidermal growth factor in breast cancer

✍ Scribed by S. Barker; G.P. Vinson

Publisher
Elsevier Science
Year
1990
Tongue
English
Weight
940 KB
Volume
22
Category
Article
ISSN
0020-711X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Epidermal growth factor promotes breast
Epidermal growth factor promotes breast cancer cell chemotaxis in CXCL12 gradients
✍ Bobak Mosadegh; Wajeeh Saadi; Shur-Jen Wang; Noo Li Jeon πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 457 KB

## Abstract The chemokine receptor CXCR4 and its ligand CXCL12 play an important role in breast cancer invasion and metastasis, and induce the chemotaxis of various types of cancer cells. Previous studies of CXCL12‐induced chemotaxis have, for the most part, relied on endpoint assays (e.g., transwe

Comparison of radioligand assay and immu
Comparison of radioligand assay and immunostaining for epidermal growth factor receptor in human breast cancer
✍ D. J. Hastrich; J. M. Dunn; S. Nicholson; P. Newcomb; Professor J. R. Farndon πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 394 KB πŸ‘ 2 views

## Abstract Epidermal growth factor (EGF) receptor status is a useful prognostic indicator in women with breast cancer. Lack of standardization and correlation of methodology for the detection of EGF receptor has hampered its further evaluation. EGF receptor status was ascertained by immunohistoche